Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)
CUSIP: 69353Y103
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 53,625,367
- Total 13F shares
- 46,465,983
- Share change
- -5,177,214
- Total reported value
- $144,025,863
- Put/Call ratio
- 13%
- Price per share
- $3.10
- Number of holders
- 97
- Value change
- -$52,160,467
- Number of buys
- 55
- Number of sells
- 56
Report period
Q4 2023
Institutions
97
Top holders
10
PMVP full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
6,563,077
|
$40,297,293 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.6%
|
4,596,378
|
$28,221,761 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
7.5%
|
4,033,721
|
$24,767,046 | — | 30 Sep 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
5.9%
|
3,163,795
|
$19,425,701 | — | 30 Sep 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.6%
|
3,000,000
|
$18,420,000 | — | 30 Sep 2023 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.9%
|
2,627,643
|
$16,133,728 | — | 30 Sep 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
4.6%
|
2,466,388
|
$15,143,622 | — | 30 Sep 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
4.4%
|
2,375,785
|
$14,587,320 | — | 30 Sep 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.4%
|
2,347,414
|
$14,413,122 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
2,042,321
|
$12,539,852 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.6%
|
1,922,357
|
$11,803,272 | — | 30 Sep 2023 | |
| INTERWEST PARTNERS X LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,502,480
|
$10,040,531 | — | 13 Jul 2021 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
3%
|
1,614,911
|
$9,915,554 | — | 30 Sep 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.4%
|
1,295,104
|
$7,951,939 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
2%
|
1,090,740
|
$6,697,144 | — | 30 Sep 2023 | |
| OUP Management Co., LLC |
13F
|
Company |
1.8%
|
989,232
|
$6,073,884 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
943,491
|
$5,793,035 | — | 30 Sep 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.7%
|
919,142
|
$5,643,528 | — | 30 Sep 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.7%
|
904,000
|
$5,550,560 | — | 30 Sep 2023 | |
| Tri Locum Partners LP |
13F
|
Company |
1.5%
|
821,384
|
$5,043,298 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
807,563
|
$4,959,041 | — | 30 Sep 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.5%
|
783,539
|
$4,810,929 | — | 30 Sep 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
1.3%
|
705,881
|
$4,334,109 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
676,625
|
$4,154,478 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
577,835
|
$3,547,823 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
542,883
|
$3,333,302 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.88%
|
471,012
|
$2,892,014 | — | 30 Sep 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
0.79%
|
421,284
|
$2,586,684 | — | 30 Sep 2023 | |
| Thilo Schroeder |
3/4/5
|
Director |
—
class O/S missing
|
1,101,283
|
$2,455,861 | — | 06 Oct 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.68%
|
365,564
|
$2,244,563 | — | 30 Sep 2023 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
0.65%
|
350,342
|
$2,151,100 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
339,729
|
$2,085,936 | — | 30 Sep 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.6%
|
322,024
|
$1,977,227 | — | 30 Sep 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.57%
|
303,824
|
$1,865,479 | — | 30 Sep 2023 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.57%
|
303,824
|
$1,865,479 | — | 30 Sep 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.5%
|
270,426
|
$1,660,416 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
269,597
|
$1,655,326 | — | 30 Sep 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.48%
|
258,538
|
$1,587,423 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
235,319
|
$1,444,859 | — | 30 Sep 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.32%
|
169,699
|
$1,041,952 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
152,311
|
$935,189 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.28%
|
150,107
|
$921,657 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
148,929
|
$914,424 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
143,681
|
$882,202 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
124,490
|
$764,369 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
95,000
|
$583,300 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.15%
|
82,185
|
$504,616 | — | 30 Sep 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.15%
|
80,600
|
$494,884 | — | 30 Sep 2023 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
74,525
|
$457,584 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
71,295
|
$437,751 | — | 30 Sep 2023 |
Institutional Holders of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) as of Q4 2023
As of 31 Dec 2023,
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,465,983 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, BlackRock Inc., ArrowMark Colorado Holdings LLC, Euclidean Capital LLC, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, Woodline Partners LP, Verition Fund Management LLC, and PFM Health Sciences, LP.
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
103
Q4 2023 holders
97
Holder diff
-6
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.